IS4805A - Method of treatment and pharmaceutical composition - Google Patents
Method of treatment and pharmaceutical compositionInfo
- Publication number
- IS4805A IS4805A IS4805A IS4805A IS4805A IS 4805 A IS4805 A IS 4805A IS 4805 A IS4805 A IS 4805A IS 4805 A IS4805 A IS 4805A IS 4805 A IS4805 A IS 4805A
- Authority
- IS
- Iceland
- Prior art keywords
- treatment
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1132896P | 1996-02-08 | 1996-02-08 | |
| GBGB9608927.1A GB9608927D0 (en) | 1996-04-29 | 1996-04-29 | Method of treatment and pharmaceutical composition |
| PCT/US1997/001799 WO1997028797A1 (en) | 1996-02-08 | 1997-02-04 | Method of treatment and pharmaceutical composion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS4805A true IS4805A (en) | 1998-07-22 |
Family
ID=26309231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS4805A IS4805A (en) | 1996-02-08 | 1998-07-22 | Method of treatment and pharmaceutical composition |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1014972A4 (en) |
| JP (1) | JPH11504044A (en) |
| KR (1) | KR19990082367A (en) |
| CN (1) | CN1210465A (en) |
| AU (1) | AU732671B2 (en) |
| BG (1) | BG102669A (en) |
| BR (1) | BR9707369A (en) |
| CA (1) | CA2245162A1 (en) |
| CZ (1) | CZ248798A3 (en) |
| EE (1) | EE9800234A (en) |
| IL (1) | IL125446A0 (en) |
| IS (1) | IS4805A (en) |
| NO (1) | NO983641L (en) |
| NZ (1) | NZ331160A (en) |
| PL (1) | PL328074A1 (en) |
| SK (1) | SK105698A3 (en) |
| TR (1) | TR199801511T2 (en) |
| WO (1) | WO1997028797A1 (en) |
| YU (1) | YU33298A (en) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7214683B1 (en) | 1994-12-30 | 2007-05-08 | Sepracor Inc. | Compositions of descarboethoxyloratadine |
| US7211582B1 (en) | 1994-12-30 | 2007-05-01 | Sepracor Inc. | Methods for treating urticaria using descarboethoxyloratadine |
| GB9723985D0 (en) | 1997-11-14 | 1998-01-14 | Zeneca Ltd | Pharmaceutical compositions |
| SK286103B6 (en) * | 1997-12-23 | 2008-03-05 | Schering Corporation | Pharmaceutical composition for treating respiratory and skin diseases, comprising at least on leucotriene antagonist and at least one antihistamine, and the use of the same |
| US6194431B1 (en) | 1998-04-14 | 2001-02-27 | Paul D. Rubin | Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| US6384038B1 (en) * | 1998-04-14 | 2002-05-07 | Sepracor Inc. | Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants |
| US6248308B1 (en) | 1998-04-14 | 2001-06-19 | Sepracor Inc. | Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma |
| US6262066B1 (en) | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
| ID29137A (en) * | 1998-07-27 | 2001-08-02 | Schering Corp | HIGH AFINITY LIGANS FOR ORL-1 NOSISEPTIN RECEPTORS |
| CO5271713A1 (en) * | 1998-09-10 | 2003-04-30 | Schering Corp | METHODS AND COMPOSITIONS TO TREAT SINUSITIS, MEDIUM OTITIS AND OTHER RELATED DISORDERS USING ANTIHISTAMINS |
| WO2000057880A1 (en) * | 1999-03-29 | 2000-10-05 | Schering Corporation | Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine |
| DE10007203A1 (en) * | 2000-02-17 | 2001-08-23 | Asta Medica Ag | Composition for treating allergic and/or vasomotor rhinitis or allergic conjunctivitis by topical or oral administration, contains synergistic combination of non-sedating antihistamine and leukotriene antagonist |
| WO2002036124A2 (en) * | 2000-10-30 | 2002-05-10 | Schering Corporation | Treatment and method using loratadine and montelukast |
| US20020198228A1 (en) * | 2001-04-03 | 2002-12-26 | Kaura Sita R. | Composition and method for the treatment of respiratory desease |
| WO2004087095A2 (en) * | 2003-03-31 | 2004-10-14 | Osmotica Costa Rica, Sociedad Anonima | Osmotic controlled release device containing zafirlukast and an h1-antagonist |
| WO2005037245A2 (en) * | 2003-10-21 | 2005-04-28 | Direct-Haler A/S | A multiple route medication for the treatment of rhinitis and asthma |
| WO2005089748A1 (en) * | 2004-03-17 | 2005-09-29 | Pfizer Limited | Combination for treating inflammatory diseases |
| EP1817034A1 (en) | 2004-10-25 | 2007-08-15 | Schering Corporation | M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders |
| TR200806298A2 (en) * | 2008-08-22 | 2010-03-22 | Bi̇lgi̇ç Mahmut | Pharmaceutical formulation |
| TW201111392A (en) | 2009-06-16 | 2011-04-01 | Schering Corp | Novel [3,2-c] heteroaryl steroids as glucocorticoid receptor agonists, compositions and uses thereof |
| KR101540191B1 (en) * | 2014-02-24 | 2015-07-28 | 성균관대학교산학협력단 | Composition comprising Loratadine for anti-inflammation |
| EP3908284A4 (en) * | 2019-01-10 | 2023-02-08 | EnliTISA (Shanghai) Pharmaceutical Co., Ltd. | New formulations containing leukotriene receptor antagonists |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4282233B1 (en) * | 1980-06-19 | 2000-09-05 | Schering Corp | Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines |
| CA1261835A (en) * | 1984-08-20 | 1989-09-26 | Masaaki Toda | (fused) benz(thio)amides |
| GB8607294D0 (en) * | 1985-04-17 | 1986-04-30 | Ici America Inc | Heterocyclic amide derivatives |
| US5565473A (en) * | 1990-10-12 | 1996-10-15 | Merck Frosst Canada, Inc. | Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
| US5270324A (en) * | 1992-04-10 | 1993-12-14 | Merck Frosst Canada, Inc. | Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists |
| US5472964A (en) * | 1992-12-22 | 1995-12-05 | Merck Frosst Canada, Inc. | Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists |
| US5595997A (en) * | 1994-12-30 | 1997-01-21 | Sepracor Inc. | Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
-
1997
- 1997-02-04 CZ CZ982487A patent/CZ248798A3/en unknown
- 1997-02-04 SK SK1056-98A patent/SK105698A3/en unknown
- 1997-02-04 PL PL97328074A patent/PL328074A1/en unknown
- 1997-02-04 TR TR1998/01511T patent/TR199801511T2/en unknown
- 1997-02-04 EP EP97905757A patent/EP1014972A4/en not_active Withdrawn
- 1997-02-04 KR KR1019980706097A patent/KR19990082367A/en not_active Application Discontinuation
- 1997-02-04 AU AU22579/97A patent/AU732671B2/en not_active Ceased
- 1997-02-04 EE EE9800234A patent/EE9800234A/en unknown
- 1997-02-04 CN CN97192149A patent/CN1210465A/en active Pending
- 1997-02-04 JP JP9528627A patent/JPH11504044A/en active Pending
- 1997-02-04 CA CA002245162A patent/CA2245162A1/en not_active Abandoned
- 1997-02-04 IL IL12544697A patent/IL125446A0/en unknown
- 1997-02-04 WO PCT/US1997/001799 patent/WO1997028797A1/en not_active Application Discontinuation
- 1997-02-04 NZ NZ331160A patent/NZ331160A/en unknown
- 1997-02-04 BR BR9707369A patent/BR9707369A/en not_active Application Discontinuation
-
1998
- 1998-07-22 IS IS4805A patent/IS4805A/en unknown
- 1998-08-05 BG BG102669A patent/BG102669A/en unknown
- 1998-08-06 YU YU33298A patent/YU33298A/en unknown
- 1998-08-07 NO NO983641A patent/NO983641L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL328074A1 (en) | 1999-01-04 |
| TR199801511T2 (en) | 1998-10-21 |
| KR19990082367A (en) | 1999-11-25 |
| SK105698A3 (en) | 1999-05-07 |
| EE9800234A (en) | 1998-12-15 |
| JPH11504044A (en) | 1999-04-06 |
| AU732671B2 (en) | 2001-04-26 |
| YU33298A (en) | 1999-11-22 |
| WO1997028797A1 (en) | 1997-08-14 |
| EP1014972A1 (en) | 2000-07-05 |
| CN1210465A (en) | 1999-03-10 |
| AU2257997A (en) | 1997-08-28 |
| NO983641D0 (en) | 1998-08-07 |
| CA2245162A1 (en) | 1997-08-14 |
| NO983641L (en) | 1998-08-07 |
| BG102669A (en) | 1999-04-30 |
| EP1014972A4 (en) | 2004-12-08 |
| CZ248798A3 (en) | 1999-01-13 |
| IL125446A0 (en) | 1999-03-12 |
| NZ331160A (en) | 2000-07-28 |
| BR9707369A (en) | 1999-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS4805A (en) | Method of treatment and pharmaceutical composition | |
| DK0890359T3 (en) | Beta-Lactam antibiotic-containing tablets and method of preparation thereof | |
| BR9407799A (en) | Composition of matter treatment method and pharmaceutical composition | |
| NO994778D0 (en) | Methods and compositions for the treatment of intestinal inflammation | |
| DK139696A (en) | Bone rail and method of making them | |
| NO975759D0 (en) | Inoculant and Method of Preparation of Inoculant | |
| NO973365D0 (en) | Method of baking and associated device | |
| DK1079809T3 (en) | Enteric coated pharmaceutical composition and method of preparation thereof | |
| DK1041879T3 (en) | Disinfectant and method of manufacture | |
| NO970532D0 (en) | System and method of blood treatment | |
| NO974671L (en) | Method of isolating a protein composition from a muscle source and protein composition | |
| IS4720A (en) | Method and pharmaceutical composition for controlling lipid concentration | |
| DK0926952T3 (en) | Antimicrobial composition and process for its preparation | |
| DK0815922T3 (en) | Desulfurization and decarbonisation process | |
| DK91793A (en) | Method of surface treatment, means of application and its use | |
| IS4466A (en) | Composition and treatment for multiple sclerosis | |
| BR9709450A (en) | Inhibitors of s-cd23 production and tnt secretion | |
| NO995034L (en) | Dental implant system and method of manufacture thereof | |
| DK0735042T3 (en) | Maltitol composition and process for its preparation | |
| IS4779A (en) | Method of producing felodipine and method of producing a pharmaceutical composition | |
| NO20001758D0 (en) | Methods and compositions for the treatment of arthritis | |
| BR9710544A (en) | Composite treatment method and pharmaceutical composition | |
| DE69717846D1 (en) | TREATMENT METHOD OF LACTATAS | |
| NO963366D0 (en) | Peptides and method of treating diabetes | |
| DK0915655T3 (en) | Method and composition for the treatment of parasites in animal environments |